These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38342656)

  • 21. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GRPR-targeting radiotheranostics for breast cancer management.
    D'Onofrio A; Engelbrecht S; Läppchen T; Rominger A; Gourni E
    Front Med (Lausanne); 2023; 10():1250799. PubMed ID: 38020178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.
    Baratto L; Jadvar H; Iagaru A
    Mol Imaging Biol; 2018 Aug; 20(4):501-509. PubMed ID: 29256046
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Wang L; Bratanovic IJ; Zhang Z; Kuo HT; Merkens H; Zeisler J; Zhang C; Tan R; Bénard F; Lin KS
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor.
    Rurarz BP; Bukowczyk M; Gibka N; Piastowska-Ciesielska AW; Karczmarczyk U; Ulański P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
    Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
    J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives.
    Gorica J; De Feo MS; Filippi L; Frantellizzi V; Schillaci O; De Vincentis G
    Expert Rev Mol Diagn; 2022 Nov; 22(11):991-996. PubMed ID: 36369779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.
    Maina T; Kaloudi A; Valverde IE; Mindt TL; Nock BA
    Nucl Med Biol; 2017 Sep; 52():57-62. PubMed ID: 28636973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor-Positive Prostate Cancer.
    Bratanovic IJ; Zhang C; Zhang Z; Kuo HT; Colpo N; Zeisler J; Merkens H; Uribe C; Lin KS; Bénard F
    J Nucl Med; 2022 Mar; 63(3):424-430. PubMed ID: 34301778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting.
    Damiana TST; Paraïso P; de Ridder C; Stuurman D; Seimbille Y; Dalm SU
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3851-3861. PubMed ID: 37584725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K; Mansi R; Tamma ML; Fani M; Forrer F; Nicolas G; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Wang L; Zhang Z; Merkens H; Zeisler J; Zhang C; Roxin A; Tan R; Bénard F; Lin KS
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Preclinical Evaluation of
    Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
    Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of bombesin peptide as a targeting ligand for the gastrin releasing peptide (GRP) receptor.
    Begum AA; Moyle PM; Toth I
    Bioorg Med Chem; 2016 Nov; 24(22):5834-5841. PubMed ID: 27670095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor.
    Parry JJ; Andrews R; Rogers BE
    Breast Cancer Res Treat; 2007 Jan; 101(2):175-83. PubMed ID: 16838112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.